Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0002115339-26-000004
Filing Date
2026-08-27
Accepted
2026-08-27 16:21:33
Documents
1
Period of Report
2026-08-26

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 7668
  Complete submission text file 0002115339-26-000004.txt   9140
Mailing Address 188 EAST BLAINE STREET, SUITE 350 SEATTLE WA
Business Address 188 EAST BLAINE STREET, SUITE 350 SEATTLE WA (206) 701-7914
Sana Biotechnology, Inc. (Issuer) CIK: 0001770121 (see all company filings)

EIN.: 831381173 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O SANA BIOTECHNOLOGY, INC. 100 TECHNOLOGY SQUARE, 2ND FLOOR CAMBRIDGE MA 02139
Business Address
PATEL DHAVALKUMAR DHIRAJLAL (Reporting) CIK: 0002115339 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39941 | Film No.: 261330760